Briefly, the pooled estimated ORs (95 % CI) for the effects of per 10 mg/dL increase in Lp(a) on CAD, CAVS and IS risk were 1.06 (95 % CI: 1.05, 1.07), 1.08 (95 % CI: 1.07, 1.10) and 1.02 (95 % CI: 1.01, 1.02), respectively. Here, LPA is linked to coronary artery disorder.